Skip to main content
. 2017 Dec 13;33(4):403–413. doi: 10.1007/s10654-017-0341-0

Table 1.

Demographic, clinical and echocardiographic characteristics of included participants, n = 2592

Mean (SD) or n (%)
Age (years) 72.6 (8.7)
Women 1591 (61.4%)
Height (cm) 167 (9)
Weight (kg) 75.0 (13.4)
Body surface area (m2) 1.83 (0.19)
Body mass index (kg/m2) 26.9 (4.0)
Systolic blood pressure (mmHg) 147 (22)
Diastolic blood pressure (mmHg) 84 (11)
Resting heart rate (bpm) 68 (11)
History of chronic obstructive pulmonary disease 267 (10.3%)
History of atrial fibrillation 163 (6.9%)
Shortness of breatha
 Validity class I 1711 (73.2%)
 Validity class II 220 (9.4%)
 Validity class III 271 (11.6%)
 Validity class VI 135 (5.8%)
Smoking
 Never 944 (36.4%)
 Former 1377 (53.2%)
 Current 269 (10.4%)
History of diabetes mellitus 243 (9.6%)
Blood pressure-lowering drugs 1131 (55.9%)
 Diuretics 465 (23.0%)
 β-blockers 639 (31.6%)
 Calcium channel blockers 232 (11.5%)
 RAAS inhibitors 640 (31.7%)
 Other 15 (0.7%)
Cholesterol-lowering drugs 617 (30.5%)
Echocardiography
 Pulmonary arterial systolic pressure (mmHg) 25.4 (6.7)
 Pulmonary arterial systolic pressure > 40 mmHg 73 (2.8%)
 Left ventricular mass (gram) 130 (38)
 Left ventricular volume (mL) 126 (31)
 Interventricular septum thickness (mm) 8 (2)
 Left ventricular posterior wall thickness (mm) 7 (1)
 Diameter of left atrium (mm) 42 (6)
 Left ventricular fractional shortening (%) 42 (6)
 Left ventricular end-diastolic dimension (mm) 51 (5)
 Diameter of the aortic root (mm) 34 (4)
E/A ratio 0.93 (0.35)
 ≤ 0.75 741 (29.9%)
 > 0.75 and < 1.50 1636 (66.1%)
 ≥ 1.50 98 (4.0%)
E/E′ ratio 11.0 (4.8)
 ≤ 8 620 (23.1%)
 > 8 and < 15 1714 (63.8%)
 ≥ 15 352 (13.1%)
E′ (m/s) 0.07 (0.02)
 Mitral valve inflow deceleration-time (ms) 204 (42)

Missing values for data on traditional cardiovascular risk factors ranged from 0 to 2.8%

Missing values for data on left heart echocardiographic parameters ranged from 0.2 to 1.7%, with exception of E/A ratio with 5.2% (mainly due to atrial fibrillation)

bpm beats per minute, E/A ratio E wave divided by A wave, E/E′ ratio E wave divided by E′, HDL high density lipid protein, RAAS renin–angiotensin–aldosterone system

aValidity classes according to the New York Heart Association (NYHA) [14], data available in 90.2% of the participants